This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Konnick, E. Q.
Right arrow Articles by Hillyard, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Konnick, E. Q.
Right arrow Articles by Hillyard, D. R.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, May 2005, p. 2133-2140, Vol. 43, No. 5
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.5.2133-2140.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan Analyte-Specific Reagent Assay and Comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 Assays

Eric Q. Konnick,1* Sheri M. Williams,1 Edward R. Ashwood,1,2 and David R. Hillyard1,2

ARUP Institute for Clinical and Experimental Pathology,1 University of Utah Health Sciences Center, Salt Lake City, Utah2

Received 18 November 2004/ Returned for modification 25 December 2004/ Accepted 18 January 2005

Performance characteristics of the COBAS hepatitis C virus (HCV) TaqMan analyte-specific reagent (TM-ASR) assay using the QIAGEN BioRobot 9604 for RNA extraction were evaluated and compared to the COBAS Amplicor HCV Monitor V2.0 (Amplicor) and Versant HCV bDNA 3.0 (Versant) assays using clinical samples. Calibration of TM-ASR using Armored RNA allowed determination of the distribution of HCV RNA in clinical samples, using 22,399 clinical samples. Limit of detection, linearity, and inter- and intraassay assay precision were determined for the TM-ASR assay using multiple clinical specimen panels across multiple determinations. Genotype specificity for the TM-ASR assay was determined using samples with different HCV RNA genotypes evaluated and compared against predetermined results. Contamination control of the TM-ASR assay was evaluated using pools of HCV RNA-positive and -negative samples tested in a checkerboard pattern over 12 runs of 96 samples. Correlation of the TM-ASR, Amplicor, and Versant assays was determined using 100 paired clinical samples and Deming regression analysis. The TM-ASR performed well with respect to linearity, precision, and contamination control. The correlation between TM-ASR and the Amplicor and Versant assays was poor, with large differences between assay results for individual samples. Calibration of the TM-ASR assay with Armored RNA allowed for a wide dynamic range and description of the distribution of HCV RNA in clinical samples.


* Corresponding author. Mailing address: ARUP Institute for Clinical and Experimental Pathology, 500 Chipeta Way, Salt Lake City, UT 84108. Phone: (801) 583-2787, ext. 2225. Fax: (801) 584-5109. E-mail: KonnicE{at}ARUPLab.com.


Journal of Clinical Microbiology, May 2005, p. 2133-2140, Vol. 43, No. 5
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.5.2133-2140.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Pyne, M. T., Konnick, E. Q., Phansalkar, A., Hillyard, D. R. (2009). Evaluation of the Abbott Investigational Use Only RealTime Hepatitis C Virus (HCV) Assay and Comparison to the Roche TaqMan HCV Analyte-Specific Reagent Assay. J. Clin. Microbiol. 47: 2872-2878 [Abstract] [Full Text]  
  • Mulligan, E. K., Germer, J. J., Arens, M. Q., D'Amore, K. L., Di Bisceglie, A., Ledeboer, N. A., Moser, M. J., Newman, A. C., O'Guin, A. K., Olivo, P. D., Podzorski, D. S., Vaughan, K. A., Yao, J. D., Elagin, S. A., Johnson, S. C. (2009). Detection and Quantification of Hepatitis C Virus (HCV) by MultiCode-RTx Real-Time PCR Targeting the HCV 3' Untranslated Region. J. Clin. Microbiol. 47: 2635-2638 [Abstract] [Full Text]  
  • Germer, J. J., Kathrotiya, J. D., Bouse, C. F., Mitchell, P. S., Yao, J. D. C. (2009). Anomalous Quantitation Standard Growth Curves in a Laboratory-Developed Hepatitis C Virus (HCV) RNA Quantification Assay Using the TaqMan HCV Analyte-Specific Reagent. J. Clin. Microbiol. 47: 2317-2320 [Abstract] [Full Text]  
  • Wei, Y., Yang, C., Wei, B., Huang, J., Wang, L., Meng, S., Zhang, R., Li, J. (2008). RNase-Resistant Virus-Like Particles Containing Long Chimeric RNA Sequences Produced by Two-Plasmid Coexpression System. J. Clin. Microbiol. 46: 1734-1740 [Abstract] [Full Text]  
  • Forman, M. S., Valsamakis, A. (2008). Performance Characteristics of a Quantitative Hepatitis C Virus RNA Assay Using COBAS AmpliPrep Total Nucleic Acid Isolation and COBAS TaqMan Hepatitis C Virus Analyte-Specific Reagent. J. Mol. Diagn. 10: 147-153 [Abstract] [Full Text]  
  • Laperche, S., Bouchardeau, F., Thibault, V., Pozzetto, B., Vallet, S., Rosenberg, A. R., Roque-Afonso, A.-M., Gassin, M., Stoll-Keller, F., Trimoulet, P., Gault, E., Chanzy, B., Mercier, B., Branger, M., Pawlotsky, J.-M., Henquell, C., Lunel, F., Gaudy-Graffin, C., Alain, S., Chaix, M.-L., Duverlie, G., Izopet, J., Lefrere, J.-J. (2007). Multicenter Trials Need To Use the Same Assay for Hepatitis C Virus Viral Load Determination. J. Clin. Microbiol. 45: 3788-3790 [Abstract] [Full Text]  
  • Highbarger, H. C., Hu, Z., Kottilil, S., Metcalf, J. A., Polis, M. A., Vasudevachari, M. B., Lane, H. C., Dewar, R. L. (2007). Comparison of the Abbott 7000 and Bayer 340 Systems for Measurement of Hepatitis C Virus Load. J. Clin. Microbiol. 45: 2808-2812 [Abstract] [Full Text]  
  • Cheng, Y., Niu, J., Zhang, Y., Huang, J., Li, Q. (2006). Preparation of His-Tagged Armored RNA Phage Particles as a Control for Real-Time Reverse Transcription-PCR Detection of Severe Acute Respiratory Syndrome Coronavirus.. J. Clin. Microbiol. 44: 3557-3561 [Abstract] [Full Text]  
  • Caliendo, A. M., Valsamakis, A., Zhou, Y., Yen-Lieberman, B., Andersen, J., Young, S., Ferreira-Gonzalez, A., Tsongalis, G. J., Pyles, R., Bremer, J. W., Lurain, N. S. (2006). Multilaboratory comparison of hepatitis C virus viral load assays.. J. Clin. Microbiol. 44: 1726-1732 [Abstract] [Full Text]  
  • Colson, P., Motte, A., Tamalet, C. (2006). Broad Differences between the COBAS Ampliprep Total Nucleic Acid Isolation-COBAS TaqMan 48 Hepatitis C Virus (HCV) and COBAS HCV Monitor v2.0 Assays for Quantification of Serum HCV RNA of Non-1 Genotypes. J. Clin. Microbiol. 44: 1602-1603 [Full Text]  
  • Sarrazin, C., Gartner, B. C., Sizmann, D., Babiel, R., Mihm, U., Hofmann, W. P., von Wagner, M., Zeuzem, S. (2006). Comparison of Conventional PCR with Real-Time PCR and Branched DNA-Based Assays for Hepatitis C Virus RNA Quantification and Clinical Significance for Genotypes 1 to 5.. J. Clin. Microbiol. 44: 729-737 [Abstract] [Full Text]